Biohit Oyj - Decisions of general meeting

RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ

BIOHIT OYJ STOCK EXCHANGE RELEASE ON 21 APRIL 2009 AT 10:30 AM                  

RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ                         

The Annual General Meeting (AGM) of Biohit Oyj held on 20 April 2009 approved   
the financial statements of the Biohit Group and the parent company, and        
discharged the members of the Board of Directors and the president and CEO from 
liability for the financial year 2008.                                          

Distribution of dividends              

In accordance with the proposal by the Board of Directors the AGM decided that  
no dividends be paid for the financial year 2008, and that the profit of EUR    
945,125.10 be transferred to the retained profit and loss account.              
Members of the Board of Directors                                               

The AGM decided that the number of members of the Board of Directors is six (6).
Furthermore, the AGM elected Professor Reijo Luostarinen, Professor Mikko       
Salaspuro, Professor Osmo Suovaniemi, MSc (Engin.), MBA Kalle Kettunen, BSc     
(Econ.) Jukka Ant-Wuorinen and MSc (Soc. Sc.) Eero Lehti as members of the Board
until the end of the next AGM.                                                  

Additionally, the AGM decided that the chairman of the Board of Directors would 
be paid a monthly fee of EUR 1,550 and the ordinary members would be paid a     
monthly fee of EUR 1,200.                                                       
Auditors                                                                        

The AGM elected authorized public accountants Ernst & Young Oy as the company's 
auditors, with APA Erkka Talvinko as the head auditor, until the end of the next
AGM.                                                                            

All decisions of the AGM were made unanimously. The minutes of the AGM are      
available for review by shareholders by 24 April 2009 at the company's website  
www.biohit.com/investors and the corporate headquarters of Biohit; address      
Laippatie 1, 00880 Helsinki.                                                    

Board of Directors of Biohit Oyj                                                


Additional information:                                                         

Osmo Suovaniemi, M.D., Ph.D., Professor          
President & CEO                                                                 
Tel: +358-9-773 861                                                             
GSM: +358-40-745 5605                                                           
Email: osmo.suovaniemi@biohit.com                                               

Distribution:                                                                   

Helsinki Exchanges                                                              
Central storage facility                                                        
Press                                                                           
www.biohit.com                                                                  


About Biohit Oyj                                                                

Biohit Oyj develops, manufactures and markets liquid handling products and      
diagnostic test systems for use in research, health care and industrial         
laboratories.                                                                   

Liquid handling products include electronic and mechanical pipettes and         
dispensers, and disposable tips, as well as pipette maintenance and calibration 
services. Diagnostics business comprises products and analysis systems for      
diagnosing, screening and prevention of gastrointestinal diseases, e.g. the     
blood-sample based GastroPanel and GastroView, for diagnosing diseases of the   
stomach and associated risks, as well as quick tests for the diagnosis of       
lactose intolerance, H. pylori infection and fecal occult blood.                

Biohit Group employs 370 people in 8 countries. Biohit Oyj is headquartered in  
Finland. Biohit has subsidiaries in France, Germany, the UK, Russia, China,     
Japan and the USA. Additionally, Biohit's products are sold by approximately 450
distributors in 70 countries. Biohit's share (BIOBV) is quoted on NASDAQ OMX    
Helsinki.                                                    

Read more at www.biohit.com